Lighthouse Canton’s LC GenInnov Global Innovation Fund Secures Investment from Kotak Mahindra Asset Management

▴ Kotak Mahindra Asset Management Co. Ltd
The investment marks a significant milestone during Lighthouse Canton’s 10th-anniversary year.

India [11th March 2025]: Lighthouse Canton, a leading global investment institution, announced that its LC GenInnov Global Innovation Fund has secured an investment from Kotak Mahindra Asset Management, one of India’s premier investment firms. This significant partnership highlights investor confidence in the fund’s strategy of investing in innovation-led public equities and marks a key milestone as Lighthouse Canton celebrates its 10th anniversary.

The LC GenInnov Global Innovation Fund focuses on identifying and investing in 30-35 high-potential companies poised for growth in the GenAI era. With a disciplined, research-driven investment philosophy, the fund targets businesses that demonstrate innovation, scalability, and profitability, offering investors diversified exposure across key themes such as Robotics, Technology, Consumer Electronics, Biotech, Healthcare, Mobility, and Material Sciences.

“We are deeply honored by the trust shown by such an esteemed institution,” said Nilesh Jasani, Fund Manager of LC GenInnov Funds. “This is a milestone that underscores the confidence placed by our investors in our vision and approach. It marks a pivotal moment for our young fund, reinforcing our commitment to delivering exceptional value to our investors through our highly differentiated and innovative strategies.”

Commenting on the investment, Nilesh Shah, CEO of Kotak Mahindra Asset Management, said: “At Kotak AMC, we constantly seek to align our portfolio with forward-looking opportunities. Our investment in GenInnov Global Innovation Fund* reflects our strong conviction in the potential of global innovation leaders and our trust in the fund’s portfolio management team to potentially deliver long-term performance." 

*The fund operates through a master-feeder structure: GenInnov Funds Limited serves as the Cayman-registered feeder fund, while GenInnov Global Master Fund is the Cayman-registered master fund.

The LC GenInnov team specializes in identifying disruptive businesses with strong fundamentals while integrating thematic, sectoral, and geographical diversification to balance cutting-edge opportunities with financial stability. The fund provides access to innovative companies driving transformation across industries, focusing on high-quality assets that create sustainable, long-term value. 

Kotak Mahindra Asset Management’s investment strengthens the LC GenInnov Global Innovation Fund’s position as a compelling solution for investors seeking exposure to global innovation leaders. The partnership also reflects Kotak’s commitment to expanding its global footprint and aligning with transformative market opportunities.

About LC GenInnov Global Innovation Fund

LC GenInnov Global Innovation Fund is a long-only global public markets fund that invests in innovation-driven companies. It selects 30-35 high-potential businesses poised for growth in the GenAI era, focusing on innovation, scalability, and profitability.

With a thematic, sectoral, and geographical diversification approach, the fund balances cutting-edge investments with financial stability, offering investors a strategic opportunity to capitalize on GenAI-driven market trends. Key themes include Robotics, Technology, Consumer Electronics, Biotech, Healthcare, Mobility, and Material Sciences.

Learn more at GenInnov.ai.

About Lighthouse Canton

Headquartered in Singapore, Lighthouse Canton is a global investment institution specializing in wealth and asset management. With over 190 experienced professionals across offices in Singapore, Dubai, India, and London, the firm oversees more than USD 4 billion in assets under management and advisory (as of December 31, 2024). Lighthouse Canton creates value through innovative investment solutions for accredited private clients, institutional investors, and an ecosystem of founders and entrepreneurs worldwide.

The firm’s Asset Management services encompass hedge funds, private equity, traditional fundamental analysis, and multiple investment strategies across real estate private equity, venture capital, venture debt, direct lending, public equities, and global macro investing.

Its Wealth Management services cater to accredited investors, including corporates, ultra-high-net-worth individuals, families and family offices, founders, and entrepreneurs. The firm provides tailored investment advisory, portfolio management, treasury, business and family office solutions, and estate and philanthropic planning.

Lighthouse Canton Pte Ltd is regulated by the Monetary Authority of Singapore (“MAS”). Lighthouse Canton Capital (DIFC) Pte Ltd is regulated by the Dubai Financial Services Authority (“DFSA”). LC Capital India Pte Ltd is regulated by the Securities and Exchange Board of India (“SEBI”). Lighthouse Canton UK Limited is regulated by the Financial Conduct Authority (“FCA”).

For more information, visit www.lighthouse-canton.com

About Kotak Mahindra Asset Management Co. Ltd. 

Kotak Mahindra Asset Management Company Limited (KMAMC) - a wholly owned subsidiary of Kotak Mahindra Bank Limited (Kotak), is the Asset Manager for Kotak Mahindra Mutual Fund (KMF). KMAMC started operations in December 1998 and as of 31st December 2024, has over 70.43 Lakh unique folios in various schemes. KMF offers schemes catering to investors with varying risk-return profiles and was the first fund house in the country to launch a dedicated gilt scheme investing only in government securities. The company is present in 96 cities and has 104 branches as of 31st December 2024. Kotak Mahindra Asset Management Company Limited (KMAMC) is the 5th Largest Fund House in India with a Quarterly Average AUM of ~4.93 lakh crore. As of December 2024

For more information, visit https://www.kotakmf.com.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026
SIMS Hospital Treats Spinal Compression in 84-Year-Old with Pacemaker Through Single-Incision Endoscopic SurgeryJuly 15, 2026
Apollo Hospitals Secunderabad Successfully Treats Achalasia Cardia Patients with Advanced POEM ProcedureJuly 15, 2026
Happiest Health Announces Entry into Healthcare Publishing BusinessJuly 15, 2026
Indian Stroke Association Expands ‘Save the Brain’ Campaign with Stroke 360° Scientific Conference in SalemJuly 15, 2026
Milann Successfully Overcomes a Hidden Fertility Barrier: Chronic Endometritis Diagnosed and Treated, Leading to Successful IVF PregnancyJuly 15, 2026
Forus Health Launches FH eyepal, a Connected Digital Eye Clinic Designed to Expand Access to Comprehensive Eye CareJuly 15, 2026
Adult ADHD Diagnostics: Why Evaluations Are Rising Later in LifeJuly 15, 2026
Healthcare Apps Changing Patient Care: How Digital Health Tools Are Reshaping India's Healthcare LandscapeJuly 15, 2026
How Stress Affects Physical Health: Understanding the Body's Response and What You Can Do About ItJuly 15, 2026
Pediatric Immunity: Realities of Seasonal Vaccines & DevelopmentJuly 14, 2026
Hormonal Imbalances in Women: PCOS and Perimenopause July 14, 2026
Erectile Dysfunction and Overall Health: Why It Is a Signal, Not Just a SymptomJuly 14, 2026
PCOS and Fertility Connection: What Every Woman Trying to Conceive Should KnowJuly 14, 2026